April 2011
Medicom CEO leadership change
Dear Bang & Olufsen Medicom Business Partner,
I am pleased to announce a number of changes in Bang & Olufsen Medicom a/s’ (Medicom) leadership, which will further strengthen our competences and growth potential:
· Morten Nielsen joins the company as CEO as of early April.
· Erik Trock-Jansen will join the Medicom Board as Chairman, and I will continue in the Board as Vice Chairman.
Medicom is very pleased to have attracted Morten as the new CEO with a focus on growth. Morten has an extensive technical and commercial background within the medical device and pharma consulting business. Before joining Medicom, Morten was a Partner with PA Consulting Group responsible for the Life Sciences business in the Nordics. Prior to PA, Morten held various leadership positions within product development, regulatory affairs, quality systems, process optimization, outsourcing, certifications (EU/FDA), and business development.
The Board is also pleased to have Erik continuing as Chairman as it will ensure continuity and momentum. Erik joined the organization as interim-CEO in June 2010 with the purpose of focusing our strategy and strengthening our organizational competences. This has now been accomplished. We now have a clear focus on development of advanced devices for injection and inhalation, in addition to electronic stethoscopes complemented with pilot and low volume production. This is supported by a stronger organization in a simplified structure.
I am thus pleased to announce a more flat and simple leadership structure. Reporting to Morten are:
Sales, Business Development & Innovation (BD&I) headed up by Soren Vestergaard Jacobsen. Soren has been 10 years with Medicom, most recently as VP R&D & Operations. Soren has also been promoted to Vice-CEO, in addition to his new position as Head of Sales, BD&I.
Product Development headed up by Kent Mosier. Kent has been with Medicom for over a year and has previously worked with medical device development and commercialization for Johnson & Johnson among other companies. Kent has more than 17 years experience in the medical device field.
Production will be headed up by Gitte Holmgaard Dale. Gitte has been five years with Medicom leading Production and Logistics.
Finance, IT & Administration will be headed up by Claus Bjerg as CFO. Claus has been with Medicom for one year and has worked with finance and IT in leadership positions for more than fifteen years.
Quality Department. We expect that a new Head will be in place by the end of 2nd quarter, until then Claus Bjerg is interim Head.
Medicom has a strong position in our focus areas - development of advanced devices for injection and inhalation, along with electronic stethoscopes complemented by pilot and low volume production. We can provide advanced solutions using our expertise in mechanics, electronics, and software along with the unique integration of development and low volume production to provide our clients with a speed to market proposition in relation to clinical trials and market launches.
First and foremost, we are interested in our clients’ success: This is our prime objective of the organizational initiatives above.
Yours Sincerely
Peer Nørkjær
Chairman of the Board
Bang & Olufsen Medicom a/s
June 2010
New CEO appointed
B&O Medicom, Struer, Denmark, June 1 2010
Henrik Kagenow has resigned from his post as CEO of Bang & Olufsen Medicom a/s 1st June by mutual agreement, and Erik Trock-Jansen has been appointed as the new CEO of Bang & Olufsen Medicom a/s 1st June.
As chairman of the board I would like to take this opportunity to thank Henrik for his great contribution to the company over the years. Henrik started in Bang & Olufsen Technology 12 years ago and helped to establish Medicom as an independent company in 2000. Today we have a strong position in drug delivery devices and a leading position in digital electronic stethoscopes. This is very much Henrik’s accomplishment.
In future we will be even more focused on operating as a consulting and development company within drug delivery device development, while expanding our position as a one stop shop for our customers. Furthermore, we need to have an even stronger focus on the commercialization of our services. This is the background for the management change today.
Erik Trock-Jansen comes to Bang & Olufsen Medicom a/s with more than 20 years of international experience in business development and start-ups in Asia. Among others, Erik has worked for EAC, McKinsey & Co., Novartis, DKSH and later in Denmark with Tytex in Ikast.
In connection with the change I wish to again thank Henrik for his work with Medicom. Henrik will be working with special projects and assignments during a transitional period. At the same time, I would like to welcome Erik.
Peer Nørkjær
Chairman of the board
Bang & Olufsen Medicom a/s
B&O Medicom is a global, Danish company, specialized in the development and manufacturing of user-friendly drug delivery device solutions and services. Inhalation, injection and tablet dispensing are and have been key focus areas for more than 20 years. Medicom employs around 80 employees in locations in Struer and in Copenhagen and more than 80% of the business is exported.
For more information about B&O Medicom: medicomnordic.com
January 2010
The LEVA® autoinjector from Bang & Olufsen Medicom wins ’2009 GOOD DESIGN™ Award’
B&O Medicom, Struer, Denmark, January 14 2010:
Designed and developed in Denmark and aimed at patients globally. The innovative and user friendly LEVA® autoinjector has received the prestigious design award ’GOOD DESIGN’.
The Chicago Athenaeum founded the GOOD DESIGN program in 1950 and today it is one of the most recognized programs for design excellence worldwide. Early participants were formable designers including Eero Saarinen, and Charles and Ray Eames.
Every year the program sees a large number of entries from around the world. This year submitted designs ranged from manned Mars exploration vehicles to clean water filtering systems. 500 designs from 35 countries received the attractive GOOD DESIGN Award for design distinction. The LEVA® auto injector was one of them.
’We are proud of this recognition of our constant strive for making drug delivery devices that are intuitive, user friendly and less stigmatizing for the patient. Patient research shows this as key to getting the optimal outcome of medical treatment’, says Peter W. Ravn who is in charge of sales and marketing with B&O Medicom. ’A well designed device, developed around patient needs has a lot of importance when it comes to injectable drugs. Patient acceptance of treatment is closely related to understanding his/her role. An easy-to-use device thus allows for home treatment which in addition lowers cost to society. This is our speciality - understanding and involving the patient and other key stakeholders when we innovate’ continues Peter W. Ravn.
LEVA® is developed with and for the patient suffering from chronic diseases like rheumatoid arthritis and multiple sclerosis. Modern, biologic drugs for home usage are often part of the treatment for these patients. B&O Medicom is working with a number of leading pharmaceutical companies to bring LEVA® to the patient.
B&O Medicom is a global, Danish company, specialized in the development and manufacturing of user-friendly drug delivery device solutions and services. Inhalation, injection and tablet dispensing are and have been key focus areas for more than 20 years. Medicom employs around 80 employees in locations in Struer and in Copenhagen and more than 80% of the business is exported.
LEVA® is a disposable autoinjector, designed to automatically deliver a single dosage when activated by the patient. It is developed by B&O Medicom and is to be used for injectable drugs.
For more information about B&O Medicom: medicomnordic.com or about Chicago Athenaeum: chi-athenaeum.org
November 2009
Lyde du kan stole på - pressemeddelse fra 3M Danmark
3M lancerer den nyeste udvikling af det velkendte Littmann® elektroniske stetoskop, der nu gennemsnitligt reducerer 85% af udefrakommende støj. Model 3100 er markant lettere at bruge end de tidligere modeller – og så er det designet og udviklet af B&O Medicom.
Click here to read more
March 2009
B&O Medicom enters collaboration to develop new, leading inhaler platform
B&O Medicom, Struer, Denmark, March 25 2009: B&O Medicom has entered a 3 year collaboration with a major pharmaceutical company to develop a next generation inhaler platform. The new platform will be leading edge when it comes to user friendliness and it will enable a safe and easy inhalation of drugs targeting asthma and COPD.
Medicom’s extensive and year long experience with the development and manufacturing of user-friendly inhalators has made it a global leader in this field. More than 40 skilled engineers and a range of patented technologies has made many, major pharmaceutical companies turn to the Struer based company. 4 of the 10 largest pharma companies are currently engaged in projects with Medicom.
The new inhalation platform represents a milestone for B&O Medicom. The outcome will be a technological solution that, especially for the elderly and for children, will be perceived as a major improvement versus current inhalers. The improvements will be reached through easier coordination between the breathing and the handling of the device. The simplicity, the user friendliness and a feedback mechanism gives confidence to the user that the medication has been performed correctly explains Henrik Kagenow, CEO of B&O Medicom.
B&O Medicom is a global, Danish company, specialised in the development and manufacturing of user-friendly drug delivery device solutions and services. Inhalation, injection and tablet dispensing are and have been key focus areas for more than 20 years. Medicom employs around 100 employees in locations in Struer and in Copenhagen and more than 80% of the business is exported.
Contact: Henrik Kagenow, CEO, tel. +45 21 61 62 97, or
Peter W. Ravn, Vice President, Sales & Marketing, tel. +45 61 20 05 04